Is PCSK9 Associated with Plasma Lipid Levels in a Sub-Saharan African Population of Patients with Obesity and Type 2 Diabetes?
Camille Maadjhou Mba,1 Wilfred Mbacham,1 Eugène Sobngwi,2,3 Jean Claude Mbanya2,3 1Department of Physiological Sciences/Biochemistry, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon; 2Department of Internal Medicine and Special...
Enregistré dans:
Auteurs principaux: | Mba CM, Mbacham W, Sobngwi E, Mbanya JC |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f434a57d7ab94f53a3ada0d9931ebba8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Effects of immunisation against PCSK9 in mice bearing melanoma
par: Amir Abbas Momtazi-Borojeni, et autres
Publié: (2019) -
Loss of Hepatic Surf4 Depletes Lipid Droplets in the Adrenal Cortex but Does Not Impair Adrenal Hormone Production
par: Xiaole Chang, et autres
Publié: (2021) -
PCSK9 Gene Polymorphisms Associated With the Risk of Myocardial Infarction in Iranian Patients
par: Farshad Namordizadeh, et autres
Publié: (2021) -
Safety and Tolerability of PCSK9 Inhibitors: Current Insights
par: Kosmas CE, et autres
Publié: (2020) -
Acaudina molpadioides mediates lipid uptake by suppressing PCSK9 transcription and increasing LDL receptor in human liver cells
par: Allicia Jack, et autres
Publié: (2021)